Izzo NJ, Yuede CM, LaBarbera KM, Limegrover CS, et al. Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification. Alzheimers Dement 2021 Feb 8. doi: 10.1002/alz.12302.
PMID: 33559354